Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isaac Aleman

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
American Journal of Ophthalmology|September 2, 2017
Preoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy: A Randomized and Controlled Trial Comparing Interval VariationJavier Castillo, Isaac Aleman, Sloan W Rush, et al.
American Journal of Ophthalmology|January 18, 2018
ReplyJavier Castillo, Isaac Aleman, Sloan W Rush, et al.
Ophthalmology. Retina|May 4, 2019
Bevacizumab before Diabetic Vitrectomy: A Clinical Trial Assessing 3 Dosing AmountsJavier Castillo Velazquez, Isaac Aleman, Sloan W Rush, et al.
The British Journal of Ophthalmology|February 2, 2019
Ziv-aflibercept versus bevacizumab administration prior to diabetic vitrectomy: a randomised and controlled trialIsaac Aleman, Javier Castillo Velazquez, Sloan W Rush, et al.
Antioxidants (Basel, Switzerland)|October 30, 2020
Antioxidants in Plants: A Valorization Potential Emphasizing the Need for the Conservation of Plant Biodiversity in CubaGabriel Llauradó Maury, Daniel Méndez Rodríguez, Sophie Hendrix, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
American Journal of Ophthalmology|September 2, 2017
Preoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy: A Randomized and Controlled Trial Comparing Interval VariationJavier Castillo, Isaac Aleman, Sloan W Rush, et al.
American Journal of Ophthalmology|January 18, 2018
ReplyJavier Castillo, Isaac Aleman, Sloan W Rush, et al.
Ophthalmology. Retina|May 4, 2019
Bevacizumab before Diabetic Vitrectomy: A Clinical Trial Assessing 3 Dosing AmountsJavier Castillo Velazquez, Isaac Aleman, Sloan W Rush, et al.
The British Journal of Ophthalmology|February 2, 2019
Ziv-aflibercept versus bevacizumab administration prior to diabetic vitrectomy: a randomised and controlled trialIsaac Aleman, Javier Castillo Velazquez, Sloan W Rush, et al.
Antioxidants (Basel, Switzerland)|October 30, 2020
Antioxidants in Plants: A Valorization Potential Emphasizing the Need for the Conservation of Plant Biodiversity in CubaGabriel Llauradó Maury, Daniel Méndez Rodríguez, Sophie Hendrix, et al.
Pageof 1